Ieq Capital LLC Invests $13.91 Million in Ventas, Inc. $VTR

Posted by Francis Steltz on Aug 23rd, 2026

Ieq Capital LLC acquired a new stake in Ventas, Inc. (NYSE:VTR – Free Report) in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 156,680 shares of the real estate investment trust’s stock, valued at approximately $13,913,000.

Several other hedge funds have also added to or reduced their stakes in the business. Callan Family Office LLC bought a new position in Ventas during the second quarter worth about $2,303,000. Paralel Advisors LLC bought a new stake in shares of Ventas in the second quarter worth about $2,655,000. Allworth Financial LP bought a new stake in shares of Ventas in the second quarter worth about $2,352,000. B. Metzler seel. Sohn & Co. AG acquired a new stake in shares of Ventas during the second quarter worth about $1,989,000. Finally, Silvant Capital Management LLC acquired a new stake in shares of Ventas during the second quarter worth about $28,000. Institutional investors and hedge funds own 94.18% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on VTR. UBS Group boosted their price objective on Ventas from $85.00 to $93.00 and gave the company a “neutral” rating in a research report on Monday, May 4th. KeyCorp increased their target price on Ventas from $90.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th. Royal Bank Of Canada raised their target price on shares of Ventas from $98.00 to $99.00 and gave the stock an “outperform” rating in a report on Friday, August 14th. Citigroup lifted their price target on shares of Ventas from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Tuesday, August 4th. Finally, JPMorgan Chase & Co. upped their price target on shares of Ventas from $93.00 to $94.00 and gave the company an “overweight” rating in a report on Monday, May 11th. Fifteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $98.00.

View Our Latest Research Report on Ventas

Insider Activity

In other Ventas news, Director Michael J. Embler acquired 2,500 shares of the business’s stock in a transaction dated Wednesday, June 3rd. The shares were acquired at an average price of $78.81 per share, with a total value of $197,025.00. Following the completion of the transaction, the director directly owned 19,202 shares in the company, valued at $1,513,309.62. This trade represents a 14.97% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.53% of the stock is owned by company insiders.

Ventas Stock Up 0.7%

Shares of Ventas stock opened at $93.32 on Friday. The business’s 50 day simple moving average is $91.36 and its 200 day simple moving average is $87.08. Ventas, Inc. has a 52-week low of $66.38 and a 52-week high of $101.60. The firm has a market cap of $47.87 billion, a PE ratio of 172.81, a P/E/G ratio of 2.15 and a beta of 0.69. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.44 and a current ratio of 0.44.

Ventas (NYSE:VTR – Get Free Report) last released its earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 EPS for the quarter, beating the consensus estimate of $0.96 by $0.01. Ventas had a return on equity of 1.99% and a net margin of 4.08%.The firm had revenue of $1.73 billion for the quarter, compared to analysts’ expectations of $1.68 billion. During the same quarter in the previous year, the business posted $0.87 EPS. The business’s quarterly revenue was up 21.7% compared to the same quarter last year. On average, analysts predict that Ventas, Inc. will post 3.89 earnings per share for the current fiscal year.

About Ventas

(Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.